Evolutionarily Conserved Human Targets of Adenosine to Inosine RNA Editing Erez Y
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Analyses of Allele-Specific Gene Expression in Highly Divergent
ARTICLES Analyses of allele-specific gene expression in highly divergent mouse crosses identifies pervasive allelic imbalance James J Crowley1,10, Vasyl Zhabotynsky1,10, Wei Sun1,2,10, Shunping Huang3, Isa Kemal Pakatci3, Yunjung Kim1, Jeremy R Wang3, Andrew P Morgan1,4,5, John D Calaway1,4,5, David L Aylor1,9, Zaining Yun1, Timothy A Bell1,4,5, Ryan J Buus1,4,5, Mark E Calaway1,4,5, John P Didion1,4,5, Terry J Gooch1,4,5, Stephanie D Hansen1,4,5, Nashiya N Robinson1,4,5, Ginger D Shaw1,4,5, Jason S Spence1, Corey R Quackenbush1, Cordelia J Barrick1, Randal J Nonneman1, Kyungsu Kim2, James Xenakis2, Yuying Xie1, William Valdar1,4, Alan B Lenarcic1, Wei Wang3,9, Catherine E Welsh3, Chen-Ping Fu3, Zhaojun Zhang3, James Holt3, Zhishan Guo3, David W Threadgill6, Lisa M Tarantino7, Darla R Miller1,4,5, Fei Zou2,11, Leonard McMillan3,11, Patrick F Sullivan1,5,7,8,11 & Fernando Pardo-Manuel de Villena1,4,5,11 Complex human traits are influenced by variation in regulatory DNA through mechanisms that are not fully understood. Because regulatory elements are conserved between humans and mice, a thorough annotation of cis regulatory variants in mice could aid in further characterizing these mechanisms. Here we provide a detailed portrait of mouse gene expression across multiple tissues in a three-way diallel. Greater than 80% of mouse genes have cis regulatory variation. Effects from these variants influence complex traits and usually extend to the human ortholog. Further, we estimate that at least one in every thousand SNPs creates a cis regulatory effect. -
BIOINFORMATICS Pages 1–7
Vol. 00 no. 00 2010 BIOINFORMATICS Pages 1–7 Integrative classification and analysis of multiple arrayCGH datasets with probe alignment Ze Tian and Rui Kuang∗ Department of Computer Science and Engineering, University of Minnesota Twin Cities, Minneapolis, USA Received on XXXXX; revised on XXXXX; accepted on XXXXX Associate Editor: XXXXXXX ABSTRACT 2009). Chromosome copy number variations can be measured by Motivation: Array comparative genomic hybridization (ArrayCGH) comparative genomic hybridization (CGH), which compares the is widely used to measure DNA copy numbers in cancer research. copy number of a differentially labeled case sample with a reference ArrayCGH data report log-ratio intensities of thousands of probes DNA from a normal individual. ArrayCGH technology based on sampled along the chromosomes. Typically, the choices of the DNA microarray can currently allow genome-wide identification locations and the lengths of the probes vary in different experiments. of regions with copy number variations at different resolutions This discrepancy in choosing probes poses a challenge in integrated (Carter, 2007). The arrayCGH data was used to discriminate healthy classification or analysis across multiple arrayCGH datasets. We patients from cancer patients and classify patients of different cancer propose an alignment based framework to integrate arrayCGH subtypes. Thus, arrayCGH data is considered as a new source of samples generated from different probe sets. The alignment biomarkers that provide important information of candidate cancer framework seeks an optimal alignment between the probe series loci for the classification of patients and discovery of molecular of one arrayCGH sample and the probe series of another sample, mechanisms of cancers (Sykes et al., 2009). -
S41436-020-01011-X.Pdf
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2020 New insights into the clinical and molecular spectrum of the novel CYFIP2-related neurodevelopmental disorder and impairment of the WRC-mediated actin dynamics Begemann, Anaïs ; Sticht, Heinrich ; Begtrup, Amber ; Vitobello, Antonio ; Faivre, Laurence ; Asadollahi, Reza ; Zweier, Markus ; Steindl, Katharina ; Rauch, Anita Abstract: PURPOSE A few de novo missense variants in the cytoplasmic FMRP-interacting protein 2 (CYFIP2) gene have recently been described as a novel cause of severe intellectual disability, seizures, and hypotonia in 18 individuals, with p.Arg87 substitutions in the majority. METHODS We assembled data from 19 newly identified and all 18 previously published individuals with CYFIP2 variants. By structural modeling and investigation of WAVE-regulatory complex (WRC)-mediated actin polymerization in six patient fibroblast lines we assessed the impact of CYFIP2 variants on the WRC. RESULTS Sixteenof 19 individuals harbor two previously described and 11 novel (likely) disease-associated missense variants. We report p.Asp724 as second mutational hotspot (4/19 cases). Genotype-phenotype correlation con- firms a consistently severe phenotype in p.Arg87 patients but a more variable phenotype inp.Asp724 and other substitutions. Three individuals with milder phenotypes carry putative loss-of-function vari- ants, which remain of unclear pathogenicity. Structural modeling predicted missense variants to disturb interactions within the WRC or impair CYFIP2 stability. Consistent with its role in WRC-mediated actin polymerization we substantiate aberrant regulation of the actin cytoskeleton in patient fibroblasts. CONCLUSION Our study expands the clinical and molecular spectrum of CYFIP2-related neurodevel- opmental disorder and provides evidence for aberrant WRC-mediated actin dynamics as contributing cellular pathomechanism. -
Supplemental Information
Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig. -
A-To-I RNA Editing Does Not Change with Age in the Healthy Male Rat Brain
Biogerontology (2013) 14:395–400 DOI 10.1007/s10522-013-9433-8 RESEARCH ARTICLE A-to-I RNA editing does not change with age in the healthy male rat brain Andrew P. Holmes • Shona H. Wood • Brian J. Merry • Joa˜o Pedro de Magalha˜es Received: 18 January 2013 / Accepted: 15 May 2013 / Published online: 26 May 2013 Ó The Author(s) 2013. This article is published with open access at Springerlink.com Abstract RNA editing is a post-transcriptional pro- Introduction cess, which results in base substitution modifications to RNA. It is an important process in generating Adenosine to inosine (A-to-I) RNA editing is a post- protein diversity through amino acid substitution and transcriptional process that alters the sequences of the modulation of splicing events. Previous studies RNA molecules. The adenosine deaminases ADAR have suggested a link between gene-specific reduc- and ADARB1 convert specific adenosine residues on tions in adenosine to inosine RNA editing and aging in RNA to inosine bases. During translation, sequencing, the human brain. Here we demonstrate that changes in and splicing, inosine is recognized as guanosine. RNA editing observed in humans with age are not Therefore, A-to-I RNA editing has important impli- observed during aging in healthy rats. Furthermore, we cations in altering specific amino acids, miRNA identify a conserved editing site in rats, in Cog3.We targeting, and in the modulation of alternative splicing propose that either age-related changes in RNA (Nishikura 2010). editing are specific to primates or humans, or that Targets of A-to-I RNA editing are often genes they are the manifestation of disease pathology. -
Spatially Clustering De Novo Variants in CYFIP2, Encoding the Cytoplasmic FMRP Interacting Protein 2, Cause Intellectual Disability and Seizures
European Journal of Human Genetics (2019) 27:747–759 https://doi.org/10.1038/s41431-018-0331-z ARTICLE Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures 1 1,2 3 3 2,4 5,6 Markus Zweier ● Anaïs Begemann ● Kirsty McWalter ● Megan T. Cho ● Lucia Abela ● Siddharth Banka ● 7 8 9,10 11 12 Bettina Behring ● Andrea Berger ● Chester W. Brown ● Maryline Carneiro ● Jiani Chen ● 13 14 13 Gregory M. Cooper ● Deciphering Developmental Disorders (DDD) Study ● Candice R. Finnila ● 3 15 16 1 5,6 17,18 Maria J. Guillen Sacoto ● Alex Henderson ● Ulrike Hüffmeier ● Pascal Joset ● Bronwyn Kerr ● Gaetan Lesca ● 19 5 20 3 9 Gloria S. Leszinski ● John Henry McDermott ● Meira R. Meltzer ● Kristin G. Monaghan ● Roya Mostafavi ● 21,22 2,4,23 24 12 21,22,25 Katrin Õunap ● Barbara Plecko ● Zöe Powis ● Gabriela Purcarin ● Tiia Reimand ● 19,26 20 27 12,28 29 Korbinian M. Riedhammer ● John M. Schreiber ● Deepa Sirsi ● Klaas J. Wierenga ● Monica H. Wojcik ● 1,30 1 31 1,2,32,33 Sorina M. Papuc ● Katharina Steindl ● Heinrich Sticht ● Anita Rauch Received: 30 May 2018 / Revised: 31 October 2018 / Accepted: 7 November 2018 / Published online: 21 January 2019 © European Society of Human Genetics 2019 1234567890();,: 1234567890();,: Abstract CYFIP2, encoding the evolutionary highly conserved cytoplasmic FMRP interacting protein 2, has previously been proposed as a candidate gene for intellectual disability and autism because of its important role linking FMRP-dependent transcription regulation and actin polymerization via the WAVE regulatory complex (WRC). Recently, de novo variants affecting the amino acid p.Arg87 of CYFIP2 were reported in four individuals with epileptic encephalopathy. -
Genome-Wide Profiling of RNA Editing Sites in Sheep Yuanyuan Zhang1,2, Deping Han1, Xianggui Dong1, Jiankui Wang1, Jianfei Chen1, Yanzhu Yao1, Hesham Y
Zhang et al. Journal of Animal Science and Biotechnology (2019) 10:31 https://doi.org/10.1186/s40104-019-0331-z RESEARCH Open Access Genome-wide profiling of RNA editing sites in sheep Yuanyuan Zhang1,2, Deping Han1, Xianggui Dong1, Jiankui Wang1, Jianfei Chen1, Yanzhu Yao1, Hesham Y. A. Darwish1,3, Wansheng Liu2* and Xuemei Deng1* Abstract Background: The widely observed RNA-DNA differences (RDDs) have been found to be due to nucleotide alteration by RNA editing. Canonical RNA editing (i.e., A-to-I and C-to-U editing) mediated by the adenosine deaminases acting on RNA (ADAR) family and apolipoprotein B mRNA editing catalytic polypeptide-like (APOBEC) family during the transcriptional process is considered common and essential for the development of an individual. To date, an increasing number of RNA editing sites have been reported in human, rodents, and some farm animals; however, genome-wide detection of RNA editing events in sheep has not been reported. The aim of this study was to identify RNA editing events in sheep by comparing the RNA-seq and DNA-seq data from three biological replicates of the kidney and spleen tissues. Results: A total of 607 and 994 common edited sites within the three biological replicates were identified in the ovine kidney and spleen, respectively. Many of the RDDs were specific to an individual. The RNA editing-related genes identified in the present study might be evolved for specific biological functions in sheep, such as structural constituent of the cytoskeleton and microtubule-based processes. Furthermore, the edited sites found in the ovine BLCAP and NEIL1 genes are in line with those in previous reports on the porcine and human homologs, suggesting the existence of evolutionarily conserved RNA editing sites and they may play an important role in the structure and function of genes. -
Chromosome 20 Shows Linkage with DSM-IV Nicotine Dependence in Finnish Adult Smokers
Nicotine & Tobacco Research, Volume 14, Number 2 (February 2012) 153–160 Original Investigation Chromosome 20 Shows Linkage With DSM-IV Nicotine Dependence in Finnish Adult Smokers Kaisu Keskitalo-Vuokko, Ph.D.,1 Jenni Hällfors, M.Sc.,1,2 Ulla Broms, Ph.D.,1,3 Michele L. Pergadia, Ph.D.,4 Scott F. Saccone, Ph.D.,4 Anu Loukola, Ph.D.,1,3 Pamela A. F. Madden, Ph.D.,4 & Jaakko Kaprio, M.D., Ph.D.1,2,3 1 Hjelt Institute, Department of Public Health, University of Helsinki, Helsinki, Finland 2 Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland 3 National Institute for Health and Welfare (THL), Helsinki, Finland 4 Department of Psychiatry, Washington University School of Medicine, St. Louis, MO Corresponding Author: Jaakko Kaprio, M.D., Ph.D., Department of Public Health, University of Helsinki, PO Box 41 (Manner- heimintie 172), Helsinki 00014, Finland. Telephone: +358-9-191-27595; Fax: +358-9-19127570; E-mail: [email protected] Received February 5, 2011; accepted June 21, 2011 2009). Despite several gene-mapping studies, the genes underlying Abstract liability to nicotine dependence (ND) remain largely unknown. Introduction: Chromosome 20 has previously been associated Recently, Han, Gelernter, Luo, and Yang (2010) performed a with nicotine dependence (ND) and smoking cessation. Our meta-analysis of 15 genome-wide linkage scans of smoking aim was to replicate and extend these findings. behavior. Linkage signals were observed on chromosomal regions 17q24.3–q25.3, 5q33.1–q35.2, 20q13.12–32, and 22q12.3–13.32. Methods: First, a total of 759 subjects belonging to 206 Finnish The relevance of the chromosome 20 finding is highlighted families were genotyped with 18 microsatellite markers residing by the fact that CHRNA4 encoding the nicotinic acetylcholine on chromosome 20, in order to replicate previous linkage findings. -
Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications
Stem Cell Rev and Rep DOI 10.1007/s12015-016-9662-8 Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications Behnam Ahmadian Baghbaderani 1 & Adhikarla Syama2 & Renuka Sivapatham3 & Ying Pei4 & Odity Mukherjee2 & Thomas Fellner1 & Xianmin Zeng3,4 & Mahendra S. Rao5,6 # The Author(s) 2016. This article is published with open access at Springerlink.com Abstract We have recently described manufacturing of hu- help determine which set of tests will be most useful in mon- man induced pluripotent stem cells (iPSC) master cell banks itoring the cells and establishing criteria for discarding a line. (MCB) generated by a clinically compliant process using cord blood as a starting material (Baghbaderani et al. in Stem Cell Keywords Induced pluripotent stem cells . Embryonic stem Reports, 5(4), 647–659, 2015). In this manuscript, we de- cells . Manufacturing . cGMP . Consent . Markers scribe the detailed characterization of the two iPSC clones generated using this process, including whole genome se- quencing (WGS), microarray, and comparative genomic hy- Introduction bridization (aCGH) single nucleotide polymorphism (SNP) analysis. We compare their profiles with a proposed calibra- Induced pluripotent stem cells (iPSCs) are akin to embryonic tion material and with a reporter subclone and lines made by a stem cells (ESC) [2] in their developmental potential, but dif- similar process from different donors. We believe that iPSCs fer from ESC in the starting cell used and the requirement of a are likely to be used to make multiple clinical products. We set of proteins to induce pluripotency [3]. Although function- further believe that the lines used as input material will be used ally identical, iPSCs may differ from ESC in subtle ways, at different sites and, given their immortal status, will be used including in their epigenetic profile, exposure to the environ- for many years or even decades. -
Mclean, Chelsea.Pdf
COMPUTATIONAL PREDICTION AND EXPERIMENTAL VALIDATION OF NOVEL MOUSE IMPRINTED GENES A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Chelsea Marie McLean August 2009 © 2009 Chelsea Marie McLean COMPUTATIONAL PREDICTION AND EXPERIMENTAL VALIDATION OF NOVEL MOUSE IMPRINTED GENES Chelsea Marie McLean, Ph.D. Cornell University 2009 Epigenetic modifications, including DNA methylation and covalent modifications to histone tails, are major contributors to the regulation of gene expression. These changes are reversible, yet can be stably inherited, and may last for multiple generations without change to the underlying DNA sequence. Genomic imprinting results in expression from one of the two parental alleles and is one example of epigenetic control of gene expression. So far, 60 to 100 imprinted genes have been identified in the human and mouse genomes, respectively. Identification of additional imprinted genes has become increasingly important with the realization that imprinting defects are associated with complex disorders ranging from obesity to diabetes and behavioral disorders. Despite the importance imprinted genes play in human health, few studies have undertaken genome-wide searches for new imprinted genes. These have used empirical approaches, with some success. However, computational prediction of novel imprinted genes has recently come to the forefront. I have developed generalized linear models using data on a variety of sequence and epigenetic features within a training set of known imprinted genes. The resulting models were used to predict novel imprinted genes in the mouse genome. After imposing a stringency threshold, I compiled an initial candidate list of 155 genes. -
High-Throughput Biochemical Analysis of In-Vivo Location Data Reveals Novel Distinct Classes of POU5F1(Oct4)/DNA Complexes. ABST
Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press High-throughput Biochemical Analysis of in-vivo Location Data Reveals Novel Distinct Classes of POU5F1(Oct4)/DNA complexes. Dean Tantin1^, Matthew Gemberling2^, Catherine Callister1, William Fairbrother* 2,3 1 2 3 Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84112; MCB Department, Brown University, Providence, Rhode Island. Center for Computational Molecular Biology, Brown University, Providence, Rhode Island 02912 ^ These Authors contributed equally to this work. *To whom correspondence should be addressed: Will Fairbrother, Brown University, Providence RI [email protected] ABSTRACT: The transcription factor POU5F1 is a key regulator of embryonic stem (ES) cell pluripotency and a known oncoprotein. We have developed a novel high-throughput binding assay called MEGAshift (microarray evaluation of genomic aptamers by shift) that we use to pinpoint the exact location, affinity and stoichiometry of the DNA-protein complexes identified by chromatin immunoprecipitation studies. We consider all genomic regions identified as POU5F1-ChIP-enriched in both human and mouse. Compared to regions that are ChIP- enriched in a single species, we find these regions more likely to be near actively transcribed genes in ES cells. We re-synthesize these genomic regions as a pool of tiled 35-mers. This oligonucleotide pool is then assayed for binding to recombinant POU5F1 by gel shift. The degree of binding for each oligonucleotide is accurately measured on a specially designed microarray. We explore the relationship between experimentally determined and computationally predicted binding strengths, find many novel functional combinations of POU5F1 half sites and demonstrate efficient motif discovery by incorporating binding information into a motif finding algorithm. -
Comparative RNA Editing in Autistic and Neurotypical Cerebella
Molecular Psychiatry (2013) 18, 1041–1048 & 2013 Macmillan Publishers Limited All rights reserved 1359-4184/13 www.nature.com/mp ORIGINAL ARTICLE Comparative RNA editing in autistic and neurotypical cerebella A Eran1,2,JBLi3, K Vatalaro2, J McCarthy2, F Rahimov2,4, C Collins2,4, K Markianos2,5, DM Margulies5,6,7, EN Brown1,8,9, SE Calvo10, IS Kohane1,5,7 and LM Kunkel2,4,5,11 Adenosine-to-inosine (A-to-I) RNA editing is a neurodevelopmentally regulated epigenetic modification shown to modulate complex behavior in animals. Little is known about human A-to-I editing, but it is thought to constitute one of many molecular mechanisms connecting environmental stimuli and behavioral outputs. Thus, comprehensive exploration of A-to-I RNA editing in human brains may shed light on gene–environment interactions underlying complex behavior in health and disease. Synaptic function is a main target of A-to-I editing, which can selectively recode key amino acids in synaptic genes, directly altering synaptic strength and duration in response to environmental signals. Here, we performed a high-resolution survey of synaptic A-to-I RNA editing in a human population, and examined how it varies in autism, a neurodevelopmental disorder in which synaptic abnormalities are a common finding. Using ultra-deep (41000 Â ) sequencing, we quantified the levels of A-to-I editing of 10 synaptic genes in postmortem cerebella from 14 neurotypical and 11 autistic individuals. A high dynamic range of editing levels was detected across individuals and editing sites, from 99.6% to below detection limits. In most sites, the extreme ends of the population editing distributions were individuals with autism.